PDGFB Gene Meningioma Familial NGS Genetic DNA Test - $500 USA | Comprehensive Cancer Risk Assessment
CBL Gene Juvenile Myelomonocytic Leukemia NGS Genetic DNA Test - $500 USA | Comprehensive Germline Mutation Testing CBL Gene Juvenile Myelomonocytic Leukemia NGS Genetic DNA Test Original price was: $700.Current price is: $500.
MSH2 Gene Muir-Torre Syndrome NGS Genetic DNA Test - $500 USD Price in USA | Comprehensive Cancer Risk Assessment MSH2 Gene Muir-Torre Syndrome NGS Genetic DNA Test Original price was: $700.Current price is: $500.
Sale!

PDGFB Gene Meningioma Familial PDGFB Related NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The PDGFB Gene Meningioma Familial PDGFB Related NGS Genetic DNA Test is a cutting-edge genetic screening that identifies mutations in the PDGFB gene associated with familial meningioma predisposition. This comprehensive test utilizes Next-Generation Sequencing (NGS) technology to provide accurate detection of hereditary cancer risks. Individuals with family history of brain tumors, multiple meningiomas, or early-onset neurological symptoms should consider this test. The analysis helps in early risk assessment, personalized surveillance planning, and informed family counseling. Results are typically available within 3-4 weeks from blood or DNA samples. This vital genetic assessment is available for $500 USD, providing crucial insights for proactive healthcare management and cancer prevention strategies.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

PDGFB Gene Meningioma Familial PDGFB Related NGS Genetic DNA Test

Comprehensive Genetic Assessment for Hereditary Meningioma Risk

The PDGFB Gene Meningioma Familial PDGFB Related NGS Genetic DNA Test represents a breakthrough in personalized cancer risk assessment, specifically targeting hereditary predisposition to meningioma development. This advanced diagnostic tool utilizes cutting-edge Next-Generation Sequencing technology to analyze the PDGFB (Platelet-Derived Growth Factor Beta) gene, which plays a critical role in cell growth regulation and has been directly linked to familial meningioma syndromes.

What This Test Measures and Detects

This comprehensive genetic analysis specifically targets:

  • Pathogenic variants in the PDGFB gene associated with familial meningioma predisposition
  • Single nucleotide polymorphisms (SNPs) affecting PDGFB expression and function
  • Copy number variations (CNVs) within the PDGFB genomic region
  • Structural rearrangements impacting PDGFB signaling pathways
  • Inheritance patterns of PDGFB-related meningioma risk

Who Should Consider This Genetic Test

This test is particularly recommended for individuals with:

  • Family history of multiple meningiomas or brain tumors
  • Personal history of early-onset meningioma (before age 50)
  • Multiple family members diagnosed with central nervous system tumors
  • Unexplained neurological symptoms with family cancer patterns
  • Planning family members seeking genetic risk assessment
  • Individuals with known PDGFB mutations in their family lineage

Clinical Benefits of PDGFB Genetic Testing

Undergoing this comprehensive genetic assessment provides numerous advantages:

  • Early Risk Identification: Detect genetic predisposition before symptom development
  • Personalized Surveillance: Tailor screening protocols based on genetic risk
  • Family Planning Guidance: Make informed reproductive decisions
  • Proactive Management: Implement preventive strategies and early interventions
  • Treatment Optimization: Guide therapeutic approaches based on genetic profile
  • Family Member Screening: Identify at-risk relatives for targeted monitoring

Understanding Your Test Results

Your genetic test results will be carefully interpreted by our expert genetic counselors:

  • Positive Result: Indicates presence of PDGFB mutation; requires enhanced surveillance and family member testing
  • Negative Result: No detected mutation; provides reassurance but doesn’t eliminate all meningioma risk
  • Variant of Uncertain Significance: Requires ongoing monitoring as research evolves
  • Carrier Status: Important for family planning and genetic counseling

Test Pricing and Details

Test Component Details
Test Name PDGFB Gene Meningioma Familial PDGFB Related NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Pre-Test Requirements

Before scheduling your test, please ensure:

  • Complete clinical history documentation
  • Genetic counseling session to create family pedigree chart
  • Discussion of testing implications with healthcare provider
  • Understanding of potential outcomes and their significance

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified genetic counselors and oncology specialists ensures comprehensive care regardless of your location.

Take Control of Your Genetic Health Today

Don’t wait to understand your genetic risk profile. Early detection through advanced genetic testing can significantly impact your healthcare journey and provide peace of mind for you and your family. Our team of experienced genetic counselors and oncology specialists are ready to guide you through every step of the testing process.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your PDGFB Gene Meningioma Familial NGS Genetic DNA Test. Take the first step toward proactive genetic health management and personalized cancer risk assessment.

SKU: 60131a2a3f22 Category:

Related products